Metagenomi, Inc. Common StockMGXNASDAQ

Revenue (LTM)

$25M

-51.8% YoY

Net Income (LTM)

$-88M

-12.6% YoY

Free Cash Flow

$-89M

Revenue CAGR (5Y)

+219.1%

Marginsimproving

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	17↑6978.2%	45↑160.2%	52↑16.8%	25↓51.8%
Gross Profit	-0	15↑10841.0%	-50↓421.0%	52↑205.3%	20↓62.0%
Operating Income	-24	-45↓86.4%	-78↓75.8%	-89↓13.3%	-96↓8.0%
Net Income	-21	-44↓103.3%	-68↓56.6%	-78↓14.4%	-88↓12.6%
EBITDA	-21	-39↓88.9%	-74↓89.5%	-83↓12.4%	-91↓8.6%
EPS Diluted	-3.62	-1.16↑68.0%	-1.82↓56.9%	-2.09↓14.8%	-2.36↓12.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	39	184↑369.4%	141↓23.8%	27↓80.5%	42↑52.3%
Total Current Assets	109	367↑236.9%	278↓24.2%	258↓7.3%	166↓35.8%
Total Assets	142	414↑191.9%	365↓12.0%	325↓11.0%	221↓31.9%
Total Current Liabilities	25	49↑92.8%	69↑41.9%	37↓45.8%	23↓38.5%
Total Liabilities	175	489↑180.1%	150↓69.4%	90↓40.0%	63↓30.3%
Total Equity	-33	-74↓128.7%	215↑389.1%	235↑9.1%	159↓32.5%
Total Debt	49	19↓62.0%	48↑159.7%	46↓5.1%	41↓11.2%
Net Debt	10	-166↓1822.1%	-92↑44.3%	18↑119.9%	-1↓105.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	24	30↑22.5%	-91↓407.5%	-109↓19.3%	-89↑18.5%
Capital Expenditure	-3	-14↓381.5%	-10↑29.8%	-3↑68.3%	-1↑81.6%
Free Cash Flow	21	16↓26.3%	-101↓742.8%	-112↓10.8%	-89↑20.3%
Stock-Based Comp	0	2↑423.2%	7↑252.8%	16↑134.1%	12↓26.9%
Net Change in Cash	-10	147↑1551.3%	-45↓130.4%	-113↓153.5%	14↑112.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance